\documentclass[10pt,a4paper]{article}

% Packages
\usepackage{fancyhdr}           % For header and footer
\usepackage{multicol}           % Allows multicols in tables
\usepackage{tabularx}           % Intelligent column widths
\usepackage{tabulary}           % Used in header and footer
\usepackage{hhline}             % Border under tables
\usepackage{graphicx}           % For images
\usepackage{xcolor}             % For hex colours
%\usepackage[utf8x]{inputenc}    % For unicode character support
\usepackage[T1]{fontenc}        % Without this we get weird character replacements
\usepackage{colortbl}           % For coloured tables
\usepackage{setspace}           % For line height
\usepackage{lastpage}           % Needed for total page number
\usepackage{seqsplit}           % Splits long words.
%\usepackage{opensans}          % Can't make this work so far. Shame. Would be lovely.
\usepackage[normalem]{ulem}     % For underlining links
% Most of the following are not required for the majority
% of cheat sheets but are needed for some symbol support.
\usepackage{amsmath}            % Symbols
\usepackage{MnSymbol}           % Symbols
\usepackage{wasysym}            % Symbols
%\usepackage[english,german,french,spanish,italian]{babel}              % Languages

% Document Info
\author{doramarin}
\pdfinfo{
  /Title (lyfjafraoi.pdf)
  /Creator (Cheatography)
  /Author (doramarin)
  /Subject (Lyfjafræði Cheat Sheet)
}

% Lengths and widths
\addtolength{\textwidth}{6cm}
\addtolength{\textheight}{-1cm}
\addtolength{\hoffset}{-3cm}
\addtolength{\voffset}{-2cm}
\setlength{\tabcolsep}{0.2cm} % Space between columns
\setlength{\headsep}{-12pt} % Reduce space between header and content
\setlength{\headheight}{85pt} % If less, LaTeX automatically increases it
\renewcommand{\footrulewidth}{0pt} % Remove footer line
\renewcommand{\headrulewidth}{0pt} % Remove header line
\renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit
% This two commands together give roughly
% the right line height in the tables
\renewcommand{\arraystretch}{1.3}
\onehalfspacing

% Commands
\newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour
\newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols
\newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns
\newcommand{\tn}{\tabularnewline} % Required as custom column type in use

% Font and Colours
\definecolor{HeadBackground}{HTML}{333333}
\definecolor{FootBackground}{HTML}{666666}
\definecolor{TextColor}{HTML}{333333}
\definecolor{DarkBackground}{HTML}{C2B938}
\definecolor{LightBackground}{HTML}{FBFAF2}
\renewcommand{\familydefault}{\sfdefault}
\color{TextColor}

% Header and Footer
\pagestyle{fancy}
\fancyhead{} % Set header to blank
\fancyfoot{} % Set footer to blank
\fancyhead[L]{
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{C}
    \SetRowColor{DarkBackground}
    \vspace{-7pt}
    {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent
        \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}}
    }
\end{tabulary}
\columnbreak
\begin{tabulary}{11cm}{L}
    \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Lyfjafræði Cheat Sheet}}}} \\
    \normalsize{by \textcolor{DarkBackground}{doramarin} via \textcolor{DarkBackground}{\uline{cheatography.com/162386/cs/39531/}}}
\end{tabulary}
\end{multicols}}

\fancyfoot[L]{ \footnotesize
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{LL}
  \SetRowColor{FootBackground}
  \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}}  \\
  \vspace{-2pt}doramarin \\
  \uline{cheatography.com/doramarin} \\
  \end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}}  \\
   \vspace{-2pt}Not Yet Published.\\
   Updated 12th July, 2023.\\
   Page {\thepage} of \pageref{LastPage}.
\end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}}  \\
  \SetRowColor{white}
  \vspace{-5pt}
  %\includegraphics[width=48px,height=48px]{dave.jpeg}
  Measure your website readability!\\
  www.readability-score.com
\end{tabulary}
\end{multicols}}




\begin{document}
\raggedright
\raggedcolumns

% Set font size to small. Switch to any value
% from this page to resize cheat sheet text:
% www.emerson.emory.edu/services/latex/latex_169.html
\footnotesize % Small font.

\begin{multicols*}{3}

\begin{tabularx}{5.377cm}{x{2.28942 cm} x{2.68758 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hjartalyf}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{\{\{ac\}\}{\bf{Lífeðlisfræði}}} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{1. Súrefni í hjartav{\"o}ðva} \tn 
% Row Count 2 (+ 1)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{2. Blóðfitur} \tn 
% Row Count 3 (+ 1)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{3. Hjartsláttaróregla} \tn 
% Row Count 4 (+ 1)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Súrefni í hjartav{\"o}ðva}}} \tn 
% Row Count 5 (+ 1)
% Row 5
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{1. Súrefnisnotkun} \tn 
% Row Count 6 (+ 1)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Hjartsláttartíðni} \tn 
% Row Count 7 (+ 1)
% Row 7
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Samdráttarkraftur} \tn 
% Row Count 8 (+ 1)
% Row 8
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{For- og eftirþj{\"o}ppun} \tn 
% Row Count 9 (+ 1)
% Row 9
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Grunnefnaskipti + efnaskipti við samdrátt} \tn 
% Row Count 10 (+ 1)
% Row 10
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{2. Súrefnis framboð} \tn 
% Row Count 11 (+ 1)
% Row 11
\SetRowColor{white}
Blóðflæði í kransæðum & Rennslisþrýstingur - lengd hjartahvíldar 	-	viðnám kransæða \tn 
% Row Count 15 (+ 4)
% Row 12
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Súrefnis mettun blóðs} \tn 
% Row Count 16 (+ 1)
% Row 13
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Súrefnis útdráttur í hjartav{\"o}ðva} \tn 
% Row Count 17 (+ 1)
% Row 14
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Blóðfitusjúkdómar}}} \tn 
% Row Count 18 (+ 1)
% Row 15
\SetRowColor{white}
1. \seqsplit{Lipopróteinsjúkdómar} & Kólesteról - Þríglýseríðar \tn 
% Row Count 20 (+ 2)
% Row 16
\SetRowColor{LightBackground}
2. \seqsplit{Blóðfituefnaskiptasjúkdómar} & Sykursýki - Vanstarfsemi skjaldkirtils \tn 
% Row Count 22 (+ 2)
% Row 17
\SetRowColor{white}
3. Aðrir blóðr{\"o}skunarkvillar & \seqsplit{Hyperkólesterólemia} \tn 
% Row Count 24 (+ 2)
% Row 18
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Hjartsláttaróregla}}} \tn 
% Row Count 25 (+ 1)
% Row 19
\SetRowColor{white}
Tegundir & Uppruni + Hraði \tn 
% Row Count 26 (+ 1)
% Row 20
\SetRowColor{LightBackground}
1. Uppruni & Supra-ventricular - Ventricular \tn 
% Row Count 28 (+ 2)
% Row 21
\SetRowColor{white}
2. Hraði & Bradycardia + Tacycardia \tn 
% Row Count 30 (+ 2)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.28942 cm} x{2.68758 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hjartalyf (cont)}}  \tn
% Row 22
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Orsakir} \tn 
% Row Count 1 (+ 1)
% Row 23
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{1. Seinkuð "after-depolarisation"} \tn 
% Row Count 2 (+ 1)
% Row 24
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{2	"Re-entry} \tn 
% Row Count 3 (+ 1)
% Row 25
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{3. 	"Ectopisk" gangráðsvirkni} \tn 
% Row Count 4 (+ 1)
% Row 26
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{4. Hjartablokk} \tn 
% Row Count 5 (+ 1)
% Row 27
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{\{\{ac\}\}{\bf{Hjarta{\"o}ng}}} \tn 
% Row Count 6 (+ 1)
% Row 28
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Angina is chest pain or discomfort that occurs if an area of your heart muscle does not get enough oxygen-rich blood.}}} \tn 
% Row Count 9 (+ 3)
% Row 29
\SetRowColor{white}
Stabíl angína & Stable angina is characterized by chest discomfort or anginal equivalent that is provoked with exertion and alleviated at rest or with nitroglycerin. \tn 
% Row Count 17 (+ 8)
% Row 30
\SetRowColor{LightBackground}
Óstabíl angína & Unstable angina is chest discomfort or pain caused by an insufficient flow of blood and oxygen to the heart. It is part of the acute coronary syndromes and may lead up to a heart attack. \tn 
% Row Count 26 (+ 9)
% Row 31
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Lyf við hjarta{\"o}ng}}\{\{ac\}\}} \tn 
% Row Count 27 (+ 1)
% Row 32
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{1. Nítr{\"o}t} \tn 
% Row Count 28 (+ 1)
% Row 33
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{2. Beta blokkar} \tn 
% Row Count 29 (+ 1)
% Row 34
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{3. Kalsíumblokkar} \tn 
% Row Count 30 (+ 1)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.28942 cm} x{2.68758 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hjartalyf (cont)}}  \tn
% Row 35
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{4. Blóðfl{\"o}guhamlandi lyf} \tn 
% Row Count 1 (+ 1)
% Row 36
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{5. Statín} \tn 
% Row Count 2 (+ 1)
% Row 37
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Nítr{\"o}t}}} \tn 
% Row Count 3 (+ 1)
% Row 38
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Virkni \{\{ac\}\}} \tn 
% Row Count 4 (+ 1)
% Row 39
\SetRowColor{LightBackground}
Auka O2 framboð & Víkka kransæðar \tn 
% Row Count 5 (+ 1)
% Row 40
\SetRowColor{white}
Minnka O2 notkun & 1. Lækka blóðþrýsting (eftirþj{\"o}ppun) 2. Lækka bláæðaþrýsting (forþj{\"o}ppun) \tn 
% Row Count 10 (+ 5)
% Row 41
\SetRowColor{LightBackground}
{\bf{Betablokkar}} & Metoprolol \tn 
% Row Count 11 (+ 1)
% Row 42
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Draga úr súrefnisnotkun + fyrirbyggja einkenni} \tn 
% Row Count 12 (+ 1)
% Row 43
\SetRowColor{LightBackground}
{\bf{Kalsíumblokkar}} & Dilitiazem \tn 
% Row Count 14 (+ 2)
% Row 44
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Draga úr súrefnissnotkun} \tn 
% Row Count 15 (+ 1)
% Row 45
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Auka framboð O2} \tn 
% Row Count 16 (+ 1)
% Row 46
\SetRowColor{white}
{\bf{Blóðfl{\"o}guhemjandi lyf}} & Magnýl \tn 
% Row Count 18 (+ 2)
% Row 47
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{\{\{ac\}\}Verkun} \tn 
% Row Count 19 (+ 1)
% Row 48
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Hindra samloðun blóðflagna með því að hindra cyclooxygenasa} \tn 
% Row Count 21 (+ 2)
% Row 49
\SetRowColor{LightBackground}
{\bf{Statín}} & Simavastatin \tn 
% Row Count 22 (+ 1)
% Row 50
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Verkun \{\{ac\}\}} \tn 
% Row Count 23 (+ 1)
% Row 51
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Hamlar HMG-CoA og minnkar kolesterol í sermi. LDL lækkar og HDL hækkar.} \tn 
% Row Count 25 (+ 2)
% Row 52
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Blóðfitulækkandi lyf}}\{\{ac\}\}} \tn 
% Row Count 26 (+ 1)
% Row 53
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Ábendingar} \tn 
% Row Count 27 (+ 1)
% Row 54
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Arfbundin blóðfituhækkun. Kransæðasjúkdómur. Fólk með marga áhættuþætti}}} \tn 
% Row Count 29 (+ 2)
% Row 55
\SetRowColor{LightBackground}
Virkni & Hindra HMG-CoA redúktasa \tn 
% Row Count 31 (+ 2)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.28942 cm} x{2.68758 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hjartalyf (cont)}}  \tn
% Row 56
\SetRowColor{LightBackground}
Aukaverkanir & V{\"o}ðvaverkir, v{\"o}ðvaniðurbrot. Hækkun lifraensíma \tn 
% Row Count 3 (+ 3)
% Row 57
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Hjartsláttaróreglulyf}}\{\{ac\}\}} \tn 
% Row Count 4 (+ 1)
% Row 58
\SetRowColor{LightBackground}
{\bf{Na-ganga blokkar}} & Lyf hafa áhrif á hrifspennu \tn 
% Row Count 6 (+ 2)
% Row 59
\SetRowColor{white}
{\bf{Betablokkar}} & Minnka sympatíska bakgrunns{\"o}rvun \tn 
% Row Count 8 (+ 2)
% Row 60
\SetRowColor{LightBackground}
{\bf{Kalíumganga blokkar}} & Kalíum efflux \tn 
% Row Count 10 (+ 2)
% Row 61
\SetRowColor{white}
{\bf{Kalsíumgangablokkar}} & \seqsplit{Affect calcium channels} and the AV node. \tn 
% Row Count 13 (+ 3)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Háþrýstilyf}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Tegundir}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{1.Þvagræsilyf} \tn 
% Row Count 2 (+ 1)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{2. β-blokkarar} \tn 
% Row Count 3 (+ 1)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{3. ACE-hemlar (og ARB blokkarar)} \tn 
% Row Count 4 (+ 1)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{4. Kalsíum-hemlar} \tn 
% Row Count 5 (+ 1)
% Row 5
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Þvagræsilyf}}} \tn 
% Row Count 6 (+ 1)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Prox tubli} \tn 
% Row Count 7 (+ 1)
% Row 7
\SetRowColor{white}
Loop agents - Lykkjulyf & Furosemide \tn 
% Row Count 9 (+ 2)
% Row 8
\SetRowColor{LightBackground}
Distal tubli & Tíazíð \tn 
% Row Count 10 (+ 1)
% Row 9
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Tíazíð þvagræsilyf veldur minnkuðu viðnámi í æðakerfinu og lægri blóðþrýsting með því að minnka blóðrúmmál, venous return og cardiac output. }}*} \tn 
% Row Count 14 (+ 4)
% Row 10
\SetRowColor{LightBackground}
Safnrás - Aldosterone stýrt, kalíum sparandi & Spiron \tn 
% Row Count 17 (+ 3)
% Row 11
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Beta blokkar}}} \tn 
% Row Count 18 (+ 1)
% Row 12
\SetRowColor{LightBackground}
Verkun & {\emph{Minnka skilvirkni hjarta + Eykur súrefnisnnotkun}} \tn 
% Row Count 21 (+ 3)
% Row 13
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Aukaverkanir} \tn 
% Row Count 22 (+ 1)
% Row 14
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Hægur hjartsláttur}}} \tn 
% Row Count 23 (+ 1)
% Row 15
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Minnkað áreynsluþol}}} \tn 
% Row Count 24 (+ 1)
% Row 16
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Lágur blóðþrýstingur}}} \tn 
% Row Count 25 (+ 1)
% Row 17
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{AV blokk}}} \tn 
% Row Count 26 (+ 1)
% Row 18
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Hjartsláttatruflanir}}} \tn 
% Row Count 27 (+ 1)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{x{2.33919 cm} x{2.63781 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Sykursýkis 2 lyf}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Bígvaníð lyf (metformin)}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Verkun \{\{ac\}\}} \tn 
% Row Count 2 (+ 1)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Eykur verkun insúlíns} \tn 
% Row Count 3 (+ 1)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Dregur úr insúlínresistance} \tn 
% Row Count 4 (+ 1)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Örvun AMP kínasa} \tn 
% Row Count 5 (+ 1)
% Row 5
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Veldur ekki hypoglycemiu} \tn 
% Row Count 6 (+ 1)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Aukaverkanir \{\{ac\}\}} \tn 
% Row Count 7 (+ 1)
% Row 7
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Ógleði + uppk{\"o}st} \tn 
% Row Count 8 (+ 1)
% Row 8
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Lystarleysi} \tn 
% Row Count 9 (+ 1)
% Row 9
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Lactic acidosis} \tn 
% Row Count 10 (+ 1)
% Row 10
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Ábending\{\{ac\}\}} \tn 
% Row Count 11 (+ 1)
% Row 11
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Sykursýki 2 - einkum feitir} \tn 
% Row Count 12 (+ 1)
% Row 12
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Sulfonylurea lyf}}\{\{ac\}\}} \tn 
% Row Count 13 (+ 1)
% Row 13
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Verkun \{\{ac\}\}} \tn 
% Row Count 14 (+ 1)
% Row 14
\SetRowColor{LightBackground}
Hvetja insúlínseytum MÞA & Hindra ATP háð kalíumg{\"o}ng \tn 
% Row Count 16 (+ 2)
% Row 15
\SetRowColor{white}
Extrapankreatísk verkun & Eykur insúlínvirkni \tn 
% Row Count 18 (+ 2)
% Row 16
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Aukaverkanir \{\{ac\}\}} \tn 
% Row Count 19 (+ 1)
% Row 17
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Hypoglycemia} \tn 
% Row Count 20 (+ 1)
% Row 18
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Leukopenia} \tn 
% Row Count 21 (+ 1)
% Row 19
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Verkun \{\{ac\}\}} \tn 
% Row Count 22 (+ 1)
% Row 20
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Sykursýki 2 - Grannir} \tn 
% Row Count 23 (+ 1)
% Row 21
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Tegundir\{\{ac\}\}} \tn 
% Row Count 24 (+ 1)
% Row 22
\SetRowColor{LightBackground}
Skammvirk & Glíbenklamíð + Tolbutamíð \tn 
% Row Count 26 (+ 2)
% Row 23
\SetRowColor{white}
Langvirk & Klórprópamíð \tn 
% Row Count 27 (+ 1)
% Row 24
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Glitazone lyf}}\{\{ac\}\}} \tn 
% Row Count 28 (+ 1)
% Row 25
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Verkun \{\{ac\}\}} \tn 
% Row Count 29 (+ 1)
% Row 26
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Minnka "hepatic glucose output"} \tn 
% Row Count 30 (+ 1)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.33919 cm} x{2.63781 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Sykursýkis 2 lyf (cont)}}  \tn
% Row 27
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Auka glucose uppt{\"o}ku í v{\"o}ðva} \tn 
% Row Count 1 (+ 1)
% Row 28
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Verka gegnum sk. PPARγ (kjarnaviðtakar)} \tn 
% Row Count 2 (+ 1)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{x{2.28942 cm} x{2.68758 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Lyf í miðtaugakerfi}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Amínósýrur}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
Örvandi & Glutamat \tn 
% Row Count 2 (+ 1)
% Row 2
\SetRowColor{LightBackground}
Hamlandi & GABA \tn 
% Row Count 3 (+ 1)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Amín}}\{\{ac\}\}} \tn 
% Row Count 4 (+ 1)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Noradrenalín\{\{ac\}\}} \tn 
% Row Count 5 (+ 1)
% Row 5
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{NA hefur {\"o}rvandi áhrif í MTK, eykur v{\"o}kuvitund, einbeitingu og hækkar blóðþrýsting.}}} \tn 
% Row Count 7 (+ 2)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Serótónín\{\{ac\}\}} \tn 
% Row Count 8 (+ 1)
% Row 7
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Hefur margþætt hlutverk í heila og tengist stjórn á svefni - v{\"o}kuvitund, verkjaskynjun, líkamshita, blóðþrýsting, matarlyst  og virkni hormóna fyrir utan áhrif á geðslag}}} \tn 
% Row Count 12 (+ 4)
% Row 8
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Acetylcholine\{\{ac\}\}} \tn 
% Row Count 13 (+ 1)
% Row 9
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Útbreitt um heilann, hefur áhrif á vitræna starfsemi (cortex), minni (hippocampus), námshæfileika og stjórn hreyfinga. Binst bæði múskrín M og nikótín N viðt{\"o}kum í MTK en aðalverkun fyrir tilstilli M-viðtaka í MTK}}} \tn 
% Row Count 18 (+ 5)
% Row 10
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Dopamine\{\{ac\}\}} \tn 
% Row Count 19 (+ 1)
% Row 11
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Taugaboðefni sem gegnir hlutverki í stjórnun og samhæfingu viðbragða allt frá einf{\"o}ldum hreyfingum upp í tilfinningaviðbr{\"o}gð og hvatir. Einnig áhrif á ýmsa vitræna starfsemi heilans eins og nám og minni og dópamín í limbíska hluta heilans hefur hlutverk varðandi stjórn tilfinninga, hvatir, fíkn o.fl.}}} \tn 
% Row Count 26 (+ 7)
% Row 12
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Histamine H\{\{ac\}\}} \tn 
% Row Count 27 (+ 1)
% Row 13
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Histamín leikur hlutverk í {\"o}rvun, svefni og árverkni.}}} \tn 
% Row Count 29 (+ 2)
% Row 14
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Noradrenalín: Lyf\{\{ac\}\}} \tn 
% Row Count 30 (+ 1)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.28942 cm} x{2.68758 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Lyf í miðtaugakerfi (cont)}}  \tn
% Row 15
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{1. Þunglyndislyf} \tn 
% Row Count 1 (+ 1)
% Row 16
\SetRowColor{white}
SNRI & Venlafaxine + Duloxetine \tn 
% Row Count 3 (+ 2)
% Row 17
\SetRowColor{LightBackground}
Þríhringlaga þunglyndislyf & Amitriptyline \tn 
% Row Count 5 (+ 2)
% Row 18
\SetRowColor{white}
2. Örvandi lyf (NA og DA aukning) & gegn ofvirkni – metýlfenidat, atomoxetín, amfetamín \tn 
% Row Count 8 (+ 3)
% Row 19
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Serótónín: Lyf \{\{ac\}\}} \tn 
% Row Count 9 (+ 1)
% Row 20
\SetRowColor{white}
1. Þunglyndislyf & SSRI, SNRI, 5HST \tn 
% Row Count 10 (+ 1)
% Row 21
\SetRowColor{LightBackground}
2. Ógleðislyf & Blokka 5HT3 viðtakann \tn 
% Row Count 12 (+ 2)
% Row 22
\SetRowColor{white}
3. Mígreinislyf & 5-HT1D og 5-HT1B agonisti \tn 
% Row Count 14 (+ 2)
% Row 23
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Acetylcholine: Lyf\{\{ac\}\}} \tn 
% Row Count 15 (+ 1)
% Row 24
\SetRowColor{white}
1. \seqsplit{Acetylcholine-esterasa-blokkar} & donezepil, rivastigmín \tn 
% Row Count 17 (+ 2)
% Row 25
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Asetýlkólíns-esterasa-blokkar notaðir við einkennum Alzheimers. Hafa ekki áhrif á framgang sjúkdóms}}} \tn 
% Row Count 20 (+ 3)
% Row 26
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{2. Geðlyf} \tn 
% Row Count 21 (+ 1)
% Row 27
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{M{\"o}rg geðrofslyf og þríhringlaga þunglyndislyf hafa andkólínerga verkun sem er róandi og kvíðastillandi }}} \tn 
% Row Count 24 (+ 3)
% Row 28
\SetRowColor{white}
a. Geðrofslyf & clozapine, klomipramine \tn 
% Row Count 26 (+ 2)
% Row 29
\SetRowColor{LightBackground}
b. Þríhringlaga þunglyndislyf & Amitriptyline \tn 
% Row Count 28 (+ 2)
% Row 30
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Dópamín: Lyf \{\{ac\}\}} \tn 
% Row Count 29 (+ 1)
% Row 31
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{1. Parkinsonlyf} \tn 
% Row Count 30 (+ 1)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{2.28942 cm} x{2.68758 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Lyf í miðtaugakerfi (cont)}}  \tn
% Row 32
\SetRowColor{LightBackground}
a. \seqsplit{Dópamínagónistar} & pramipexole \tn 
% Row Count 2 (+ 2)
% Row 33
\SetRowColor{white}
b. MAO-B hemlar & Rasagiline, Selegilline \tn 
% Row Count 4 (+ 2)
% Row 34
\SetRowColor{LightBackground}
c. COMT hemill & Entacapone \tn 
% Row Count 5 (+ 1)
% Row 35
\SetRowColor{white}
d. Levódópa forefni dópamíns & Madopar \tn 
% Row Count 7 (+ 2)
% Row 36
\SetRowColor{LightBackground}
2. Þunglyndislyf & bupropion - Wellbutrin, Zyban \tn 
% Row Count 9 (+ 2)
% Row 37
\SetRowColor{white}
3. Geðrofslyf & Blokka sérstækt DA viðtaka \tn 
% Row Count 11 (+ 2)
% Row 38
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Histamine H: Lyf \{\{ac\}\}} \tn 
% Row Count 12 (+ 1)
% Row 39
\SetRowColor{white}
1. Geðlyf - blokkun & Kvíðastillandi áhrif \tn 
% Row Count 14 (+ 2)
% Row 40
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{2. Ofnæmsilyf} \tn 
% Row Count 15 (+ 1)
% Row 41
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Smápeptíð}}\{\{ac\}\}} \tn 
% Row Count 16 (+ 1)
% Row 42
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{Glutamate} \tn 
% Row Count 17 (+ 1)
% Row 43
\SetRowColor{white}
1. NMDA viðtaka blokkar & Memantine, Ketamine, Phencyclidine \tn 
% Row Count 19 (+ 2)
% Row 44
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{GABA} \tn 
% Row Count 20 (+ 1)
% Row 45
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{1. Benzódíazepín-samb{\"o}nd} \tn 
% Row Count 21 (+ 1)
% Row 46
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Annað}}\{\{ac\}\}} \tn 
% Row Count 22 (+ 1)
% Row 47
\SetRowColor{white}
1. Sterar & Estrogen, androgen \tn 
% Row Count 23 (+ 1)
% Row 48
\SetRowColor{LightBackground}
2. G{\"o}s & Nitric oxide + Carbon monoxide \tn 
% Row Count 25 (+ 2)
% Row 49
\SetRowColor{white}
3. Lípíð & Prostaglandin + Endocannabinoids \tn 
% Row Count 27 (+ 2)
% Row 50
\SetRowColor{LightBackground}
4. Neuropeptíð & Substabce P, Neuropeptide Y, endorphine \tn 
% Row Count 29 (+ 2)
% Row 51
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{5. Neurotrophins og cytokine} \tn 
% Row Count 30 (+ 1)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{p{0.4977 cm} p{0.4977 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Lungnalyf}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Astmi}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{5.377cm}{x{1.29402 cm} x{3.68298 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Sýklalyf}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Cephalosporin}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 1
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Cephalosporin I} \tn 
% Row Count 2 (+ 1)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Beta laktam lyf, þrjár kynslóðir Hamla myndun peptidoglycans líkt og penicillin}}} \tn 
% Row Count 4 (+ 2)
% Row 3
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Cephalosporin II} \tn 
% Row Count 5 (+ 1)
% Row 4
\SetRowColor{LightBackground}
1. Kynslóð 1 & Cefazolin (kefzol) + cephalexin (Keflex) \tn 
% Row Count 7 (+ 2)
% Row 5
\SetRowColor{white}
2. Kynslóð 2 & Cefuroxime (Zinacef) \tn 
% Row Count 9 (+ 2)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Öndunarfæra- og kviðarholssýkingar}}} \tn 
% Row Count 10 (+ 1)
% Row 7
\SetRowColor{white}
3. Kynslóð 3 & Ceftriaxone (Rocephalin) \tn 
% Row Count 12 (+ 2)
% Row 8
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Lungnabólgur, nýrnasýkingar, hjartaþelsbólga, heilahimnubólga}}} \tn 
% Row Count 14 (+ 2)
% Row 9
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Penicillin}}\{\{ac\}\}} \tn 
% Row Count 15 (+ 1)
% Row 10
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Bindast Penicillin bindipróteinum Hindrar krossbindingu peptidoglycana sem eru síðasta skref í myndun frumuveggjar baktería }}} \tn 
% Row Count 18 (+ 3)
% Row 11
\SetRowColor{white}
Notkun: & Streptokokkar, pneumokokkar, enterokokkar, n menigitis \tn 
% Row Count 20 (+ 2)
% Row 12
\SetRowColor{LightBackground}
\seqsplit{Aukaverkanir:} & Lyfjaútbrot + ofnæmi \tn 
% Row Count 22 (+ 2)
% Row 13
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Vancomycin}}\{\{ac\}\}} \tn 
% Row Count 23 (+ 1)
% Row 14
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\emph{Hindrar myndun peptidoglycans í frumuvegg baktería- svipað og PCN }}} \tn 
% Row Count 25 (+ 2)
% Row 15
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{Notkun:} \tn 
% Row Count 26 (+ 1)
% Row 16
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{PO: Clostridium difficile niðurgangur} \tn 
% Row Count 27 (+ 1)
% Row 17
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{IV: Ýmsar alvarlegar sýkingar, MÓSA (MRSA) sýkingar, varalyf ef penicillin ofnæmi} \tn 
% Row Count 29 (+ 2)
% Row 18
\SetRowColor{LightBackground}
\seqsplit{Aukaverkanir:} & Red man-neck heilkenni. Nýrnabilun. \tn 
% Row Count 31 (+ 2)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{5.377cm}{x{1.29402 cm} x{3.68298 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Sýklalyf (cont)}}  \tn
% Row 19
\SetRowColor{LightBackground}
\mymulticolumn{2}{x{5.377cm}}{{\bf{Makrólíðar}}\{\{ac\}\}} \tn 
% Row Count 1 (+ 1)
% Row 20
\SetRowColor{white}
\mymulticolumn{2}{x{5.377cm}}{{\emph{ Hindra próteinmyndun, 50s subeining ríbósóms}}} \tn 
% Row Count 3 (+ 2)
% Row 21
\SetRowColor{LightBackground}
Tegundir: & Erythromycin, clarithromycin og azithromycin \tn 
% Row Count 5 (+ 2)
% Row 22
\SetRowColor{white}
Notkun: & Atypiskar lungnabólgur Gastroenteritis vegna Camphylobacter Jejuni \tn 
% Row Count 8 (+ 3)
% Row 23
\SetRowColor{LightBackground}
\seqsplit{Aukaverkanir:} & Ógleði, uppk{\"o}st, niðurgangur Ofnæmisviðbr{\"o}gð \tn 
% Row Count 10 (+ 2)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}


% That's all folks
\end{multicols*}

\end{document}